Published in Ann Intern Med on November 15, 1995
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest (2006) 3.41
Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int (2014) 2.86
Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension (2008) 2.84
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol (2008) 2.48
How to measure renal function in clinical practice. BMJ (2006) 2.22
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant (2009) 2.17
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med (2014) 2.02
Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol (2009) 1.98
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Hypertension (2011) 1.65
Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol (2004) 1.56
High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol (2008) 1.50
Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant (2009) 1.49
Diabetic nephropathy. Diabetol Metab Syndr (2009) 1.43
beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity. Proc Natl Acad Sci U S A (2006) 1.43
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ (2013) 1.43
Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol (2012) 1.42
A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet (2007) 1.42
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int (2011) 1.37
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol (2013) 1.23
Dietary protein intake and renal function. Nutr Metab (Lond) (2005) 1.18
Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia (2011) 1.15
Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol (2003) 1.15
The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional survey. BMC Public Health (2009) 1.14
Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol (2008) 1.11
Managing progressive renal disease before dialysis. Can Fam Physician (1999) 1.08
Implementation of a CKD checklist for primary care providers. Clin J Am Soc Nephrol (2014) 1.07
Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol (2012) 1.06
Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci U S A (1999) 1.06
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients. Nephron Clin Pract (2009) 1.05
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc (2004) 1.04
What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease. Pediatr Nephrol (2009) 1.03
Risk factors for progression of chronic kidney disease. Curr Opin Pediatr (2010) 1.03
Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis (2013) 1.02
Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc (2002) 1.00
Complement in glomerular injury. Semin Immunopathol (2007) 0.99
Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res (2012) 0.99
Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol (2008) 0.99
Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis. Br J Clin Pharmacol (2013) 0.98
Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol (2013) 0.96
Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity. Front Physiol (2012) 0.95
The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res (2013) 0.94
Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney Int (2014) 0.94
Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding. PLoS One (2011) 0.92
Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials. Br J Clin Pharmacol (2013) 0.92
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis (2014) 0.92
Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR. Case Rep Nephrol (2014) 0.91
Treatment of hypertension in children and adolescents. Pediatr Nephrol (2007) 0.91
Can vitamin D slow down the progression of chronic kidney disease? Pediatr Nephrol (2011) 0.90
Progression of pediatric CKD of nonglomerular origin in the CKiD cohort. Clin J Am Soc Nephrol (2015) 0.90
Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol (2003) 0.89
Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals. Diabetes Care (2008) 0.88
Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.88
The glomerular filtration barrier: components and crosstalk. Int J Nephrol (2012) 0.87
Lipid droplet-associated proteins protect renal tubular cells from fatty acid-induced apoptosis. Am J Pathol (2008) 0.86
Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res (2015) 0.86
Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. J Clin Invest (2014) 0.86
Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension. J Diabetes Complications (2008) 0.86
Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol Dial Transplant (2011) 0.86
Proteinuria in dogs and cats. Can Vet J (2012) 0.86
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol (2002) 0.85
Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis. Int J Nephrol Renovasc Dis (2011) 0.84
Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis (2015) 0.84
Predictive factors of progression of chronic renal insufficiency: a multivariate analysis. Pediatr Nephrol (2003) 0.84
Optimizing blood pressure control in patients with chronic kidney disease. Proc (Bayl Univ Med Cent) (2010) 0.83
Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan. Heart Vessels (2012) 0.83
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study. PLoS One (2011) 0.83
Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study. BMC Nephrol (2012) 0.83
Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate. Hypertension (2014) 0.83
Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset. Nephrol Dial Transplant (2010) 0.83
Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users. Am J Kidney Dis (2008) 0.82
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension. CMAJ (1999) 0.82
Educational paper: Progression in chronic kidney disease and prevention strategies. Eur J Pediatr (2012) 0.82
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors. EJC Suppl (2013) 0.81
Effects of 5/6 nephrectomy on renal function and blood pressure in mice. Int J Physiol Pathophysiol Pharmacol (2012) 0.81
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol (2009) 0.81
Hypertension and chronic kidney disease: controversies in pathogenesis and treatment. Minerva Urol Nefrol (2013) 0.81
The Relationship between Anemia and the Initiation of Dialysis in Patients with Type 2 Diabetic Nephropathy. Diabetes Metab J (2015) 0.81
Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease. Heart Vessels (2009) 0.80
Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest (1997) 0.80
Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease. ISRN Nephrol (2014) 0.80
Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults. BMC Nephrol (2013) 0.80
2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens (2015) 0.79
Comparison of estimated protein output and urine protein: creatinine ratio in first and second voids with 24-hour urine protein. Nephron Extra (2011) 0.79
Cyprinus carpio Decoction Improves Nutrition and Immunity and Reduces Proteinuria through Nephrin and CD2AP Expressions in Rats with Adriamycin-Induced Nephropathy. Evid Based Complement Alternat Med (2012) 0.79
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis (2011) 0.79
Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease. J Immunol Res (2015) 0.79
Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients. Clin Exp Nephrol (2015) 0.79
Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies. Pediatr Nephrol (2016) 0.78
The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis. Clin Nephrol (2013) 0.78
Challenges and scientific considerations in hypertension management reflected in the 2012 recommendations of the Canadian Hypertension Education Program. Open Med (2012) 0.78
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Pulmonary Calcification in Negative Reactors to Tuberculin. Am J Public Health Nations Health (1945) 19.24
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med (1992) 4.33
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int (1997) 4.22
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis (2001) 3.68
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med (1976) 3.47
Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg (1995) 3.21
Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) (1976) 3.11
Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology (1992) 2.94
Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis (1990) 2.91
Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int (2006) 2.85
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
T7-induced DNA polymerase. Characterization of associated exonuclease activities and resolution into biologically active subunits. J Biol Chem (1979) 2.76
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol (2001) 2.53
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis (2001) 2.41
Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int (2008) 2.41
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int (2006) 2.18
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
In vivo functional proteomics: mammalian genome annotation using CD-tagging. Biotechniques (2002) 2.16
Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol (1972) 2.15
The protective effect of a cut-resistant glove liner. A prospective, randomised trial. J Bone Joint Surg Br (1998) 2.03
Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol (1993) 1.99
Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry (1988) 1.97
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int (1973) 1.88
Integration of visual and auditory information in bimodal neurones in the guinea-pig superior colliculus. Exp Brain Res (1985) 1.88
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant (2008) 1.88
Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity (2000) 1.87
Expression of the potato tuber ADP-glucose pyrophosphorylase in Escherichia coli. J Biol Chem (1993) 1.83
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med (1995) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med (1995) 1.80
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int (1982) 1.78
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int (1976) 1.77
Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med (1987) 1.76
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. Am J Physiol (1967) 1.72
Recurrence of primary spontaneous pneumothorax. Thorax (1997) 1.71
Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest (1975) 1.70
Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int (2006) 1.68
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics (2000) 1.67
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.66
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int (2000) 1.66
Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment. J Am Coll Cardiol (1994) 1.64
Raised intraocular pressure (IOP) and perioperative visual loss in laparoscopic colorectal surgery: a catastrophe waiting to happen? A systematic review of evidence from other surgical specialities. Tech Coloproctol (2012) 1.64
C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. J Immunol (1972) 1.64
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol (2000) 1.61
Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med (1997) 1.60
Crinkling of epicardial defibrillator patches. A common and serious problem. J Thorac Cardiovasc Surg (1995) 1.59
A natriuretic factor in the serum of patients with chronic uremia. J Clin Invest (1972) 1.59
A new classification of ocular surface burns. Br J Ophthalmol (2001) 1.56
A single mutation that increases maize seed weight. Proc Natl Acad Sci U S A (1996) 1.56
Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis. Br J Ophthalmol (2008) 1.56
The role of monocytes in serum sickness nephritis. J Exp Med (1979) 1.55
Macroscopic hematuria as a presenting manifestation of oliguric acute tubular necrosis. Am J Kidney Dis (1993) 1.53
The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol (1994) 1.52
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest (1999) 1.50
Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med (2001) 1.50
Attitudes to the use of health outcome questionnaires in the routine care of patients with diabetes: a survey of general practitioners and practice nurses. Br J Gen Pract (1998) 1.50
Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol (1989) 1.50
Effect of parathyroid hormone on rat heart cells. J Clin Invest (1981) 1.50
Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. J Clin Invest (1971) 1.50
Do foot examinations reduce the risk of diabetic amputation? J Fam Pract (2000) 1.47
Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis (1992) 1.47
Antidiuretic principle in tuberculous lung tissue of a patient with pulmonary tuberculosis and hyponatremia. Ann Intern Med (1970) 1.46
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials (1991) 1.45
Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens (1992) 1.45
Study of intestinal absorption of calcium in patients with renal failure. Kidney Int (1973) 1.45
Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis. J Crit Care (1999) 1.45
Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats. Nephrol Dial Transplant (1997) 1.44
Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis (1996) 1.44
Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2012) 1.42
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int (1995) 1.42